Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Moodys
Mallinckrodt
Baxter
McKesson

Last Updated: May 26, 2022

Chartwell Rx Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has one hundred and sixty-one approved drugs.



Summary for Chartwell Rx
US Patents:0
Tradenames:107
Ingredients:100
NDAs:161

Drugs and US Patents for Chartwell Rx

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx WARFARIN SODIUM warfarin sodium TABLET;ORAL 040196-006 Sep 30, 1997 DISCN No No See Plans and Pricing See Plans and Pricing
Chartwell Rx REPAGLINIDE repaglinide TABLET;ORAL 078555-002 Jan 22, 2014 AB RX No No See Plans and Pricing See Plans and Pricing
Chartwell Rx PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 087918-001 Dec 22, 1983 DISCN No No See Plans and Pricing See Plans and Pricing
Chartwell Rx SPIRONOLACTONE spironolactone TABLET;ORAL 086809-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Chartwell Rx WARFARIN SODIUM warfarin sodium TABLET;ORAL 040196-009 Jul 26, 2000 DISCN No No See Plans and Pricing See Plans and Pricing
Chartwell Rx METHYCLOTHIAZIDE methyclothiazide TABLET;ORAL 089837-001 Aug 18, 1988 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Mallinckrodt
AstraZeneca
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.